Other Information.
+Added: Our directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may
+Added: represent a non-Rule 10b5-1 trading arrangement under the Exchange Act.
+Added: During the quarter ended September 30, 2023, no such plans or other arrangements were adopted or terminated.
See the Exhibit Index immediately following the signature page of this Quarterly Report on Form 10-Q.
1 unchanged sentence
ADMA Biologics, Inc.
−Removed: August 9, 2023
+Added: November 8, 2023
President and Chief Executive Officer
−Removed: August 9, 2023
+Added: November 8, 2023
/s/ Brian Lenz
6 unchanged sentences
Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following materials from ADMA Biologics, Inc.’s Form 10-Q for the quarter ended June 30 2023, formatted in Extensible Business Reporting Language (XBRL):
−Removed: (i) Condensed Consolidated Balance
−Removed: Sheets as of June 30, 2023 (Unaudited) and December 31, 2022, (ii) Condensed Consolidated Statements of Operations (Unaudited) for the three months and six months ended June 30, 2023 and 2022, (iii) Condensed Consolidated
−Removed: Statements of Changes in Stockholders' Equity (Unaudited) for the three and six months ended June 30, 2023 and 2022, (iv) Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2023 and 2022,
+Added: The following materials from ADMA Biologics, Inc.’s Form 10-Q for the quarter ended September 30 2023, formatted in Extensible Business Reporting Language (XBRL):
+Added: (i) Condensed Consolidated Balance Sheets as
+Added: of September 30, 2023 (Unaudited) and December 31, 2022, (ii) Condensed Consolidated Statements of Operations (Unaudited) for the three months and nine months ended September 30, 2023 and 2022, (iii) Condensed Consolidated Statements
+Added: of Changes in Stockholders' Equity (Unaudited) for the three and nine months ended September 30, 2023 and 2022, (iv) Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2023 and 2022,
and (v) Notes to (Unaudited) Condensed Consolidated Financial Statements.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.